US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Nexalin Technologies Inc (NXL)
Nexalin Technologies Inc (NXL) ニュース

NXL

Nexalin Technologies (NXL)

Nexalin Technologies Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NXL

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	21 : 30	GlobeNewswire Inc.	Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23	NASDAQ:NXL	Nexalin Technologies Inc
2024/04/25	23 : 44	GlobeNewswire Inc.	Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements	NASDAQ:NXL	Nexalin Technologies Inc
2024/04/09	21 : 30	GlobeNewswire Inc.	Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing	NASDAQ:NXL	Nexalin Technologies Inc
2024/04/05	02 : 00	GlobeNewswire Inc.	Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device	NASDAQ:NXL	Nexalin Technologies Inc
2024/04/02	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board	NASDAQ:NXL	Nexalin Technologies Inc
2024/03/28	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego	NASDAQ:NXL	Nexalin Technologies Inc
2024/03/14	21 : 30	GlobeNewswire Inc.	Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology	NASDAQ:NXL	Nexalin Technologies Inc
2024/03/13	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”	NASDAQ:NXL	Nexalin Technologies Inc
2024/02/08	22 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device	NASDAQ:NXL	Nexalin Technologies Inc
2024/01/23	22 : 30	GlobeNewswire Inc.	Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System	NASDAQ:NXL	Nexalin Technologies Inc
2024/01/11	22 : 30	GlobeNewswire Inc.	Nexalin Technology Unveils Next-Generation HALO™ Clarity	NASDAQ:NXL	Nexalin Technologies Inc
2023/12/18	22 : 30	GlobeNewswire Inc.	Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression	NASDAQ:NXL	Nexalin Technologies Inc
2023/11/14	06 : 38	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NXL	Nexalin Technologies Inc
2023/11/14	04 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXL	Nexalin Technologies Inc
2023/10/25	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter	NASDAQ:NXL	Nexalin Technologies Inc
2023/10/16	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures	NASDAQ:NXL	Nexalin Technologies Inc
2023/10/06	01 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXL	Nexalin Technologies Inc
2023/10/06	01 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXL	Nexalin Technologies Inc
2023/10/06	01 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXL	Nexalin Technologies Inc
2023/09/29	05 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXL	Nexalin Technologies Inc
2023/08/11	04 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NXL	Nexalin Technologies Inc
2023/08/07	21 : 30	GlobeNewswire Inc.	Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms	NASDAQ:NXL	Nexalin Technologies Inc
2023/08/03	21 : 30	GlobeNewswire Inc.	Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/26	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/10	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/01	04 : 15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/01	04 : 15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/01	04 : 15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/01	04 : 11	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:NXL	Nexalin Technologies Inc
2023/07/01	04 : 11	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:NXL	Nexalin Technologies Inc

Showing the most relevant articles for your search:NASDAQ:NXL

US Dollar vs Euro

BNP Paribas (QX)

Financial Select Sector

Energy Select Sector SPDR

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約